The hottest Vaccinology Substack posts right now

Repeated mRNA boosters can drive a progressive shift toward IgG4 antibodies that keep binding the spike protein but weaken Fc effector functions (like ADCC and complement) and have been linked to higher breakthrough infection risk.
The class switch is driven by IL‑10–rich germinal center signals and becomes encoded in long‑lived memory B cells and plasma cells, so it is durable and not detected by standard total anti‑spike IgG tests.
Because this effect is cumulative and immunologically specific, booster policy and surveillance should be risk‑stratified with longer minimum intervals, pediatric reassessment, and prospective monitoring using IgG subclass assays and targeted safety studies.

Your first childhood flu exposure permanently shapes how your immune system responds to later vaccines, so repeated shots or similar antigens can make the body recall old answers instead of making updated protection.
As people age their immune systems lose naive cells, germinal center function declines, and chronic inflammation rises, which makes older adults both the most vulnerable to flu and the least likely to mount a strong vaccine response.
Current one-size-fits-all vaccination policy doesn’t account for imprinting, repeat-vaccination effects, or immunosenescence; we need clearer communication and investment in better vaccine platforms and strategies (non-egg production, adjuvants, or immunomodulation).

Talk to vaccine skeptics with empathy and without sneering; listening and explaining things simply helps conversations go much better.
Distrust of institutional scientists and Big Pharma fuels skepticism, but independent scientists also deserve critical scrutiny—avoid reflexive tribalism on either side.
Vaccine beer might appeal to some skeptics if it’s transparent, clearly not coercive (for example, visibly colored), and developed with feedback from skeptical communities beyond one’s family.

Pregnancy doesn't simply suppress immunity; it systemically recalibrates immune responses via hormones, increasing some defenses and restraining others to allow fetal tolerance.
Vaccines still protect pregnant people, but pregnancy often narrows antibody breadth against new variants and shifts responses toward innate effector mechanisms, so vaccine formulation or timing may deserve dedicated study.
Breast milk provides a personalized mucosal immune layer—mainly secretory IgA—that protects the baby's gut and airways, helps shape the infant microbiome and immune development, and differs depending on whether the mother had infection (IgA) or intramuscular vaccination (IgG).

African swine fever was detected near a high-security research lab and genetic analysis showed the strain closely matches a laboratory reference virus, prompting police raids and a sealed criminal investigation into a possible lab release.
Spain’s pork industry is a global powerhouse, and the outbreak triggered immediate export bans and urgent containment actions, with a real risk of massive economic losses if domestic farms become infected.
The case highlights serious gaps in biosafety and oversight for high-containment, internationally funded pathogen research, underscoring the need for greater transparency, clear accountability, and stronger governance to prevent accidental releases.

Get a weekly roundup of the best Substack posts, by hacker news affinity:

A $100,000 prize is offered to any US-based epidemiologist, infectious-disease specialist, or biostatistics professor with an h-index of 10+ to debate the mRNA COVID vaccine risk‑vs‑benefit live for one hour.
The challenge hinges on Czech KCOR data and asks the expert to show that the cumulative net mortality benefit of two or three mRNA doses in the first two years likely exceeds the mortality risk; the debate will have three mutually agreeable unbiased judges and 30 minutes per side.
Authorized employees of Pfizer or Moderna are explicitly invited to participate, framing the offer as a public call to prompt a real-time scientific dispute and draw attention to the vaccine safety question.

KCOR v6 fits a Gompertz gamma‑frailty model to cohorts' cumulative hazards to remove heterogeneity and allow fair comparisons between vaccinated and unvaccinated groups.
Applied to Czech data, KCOR shows a net harm signal (KCOR > 1) for mRNA COVID vaccines over time, with boosters appearing especially harmful in the weeks after vaccination.
The method depends on assumptions (Gompertz mortality, gamma frailty, and that vaccine harm subsided by mid‑2022) and has limits: it can miss very early post‑shot spikes, long‑term monotonic risk increases, and non‑proportional hazard effects.